Medical Professionals:
Request a
Product Sample
We want to continuously educate the public about our innovative products and want to bring you what the media thinks of HemCon and its products.

On this page you can find a variety of resources including:
 Featured News Coverage   |   See All News >

A New Hemostasis Tool after Percutaneous Angioplasty: The Hemcontm Pad Hemostasis Device
Citation: Oozawa S, Akagi T, Sano S (2014) A New Hemostasis Tool after Percutaneous Angioplasty: The Hemcontm Pad Hemostasis Device. J
Vasc Med Surg 2: 125. doi: 10.4172/2329-6925.1000125

Surgical Products: HemCon Patch - Flexible Hemostatic Dressing Provides Comfort and Care

Линия Здоровья 6 апреля 2010: KytoStat in the News - katka6223  Передача: ЛинияЗдоровья, Открытая Студия Ведущие: Давид Кон и Анна Шац Гость: Катя Навэ, медсестра Тема: Новинки для улучшения качества жизни. Nurse on a Russian Television Channel in Israel recommends KytoStat to be used on every anticoagulated patient and for every home.

 Contemporary Pediatrics: Nosebleeds - a tissue-free way to plug up nasal passages Tax on medical device makers will hurt jobs, patients
: Can New Hemostatic Dressings Facilitate Sharp Debridement In High-Risk Patients?

World Pharma News - Pharmaceutical Business Review: Drug Discovery & Development - Medical News Today
HemCon Medical Technologies, Inc. Announces Improved Results From Live Nail Infection Study: Testing Continues to Validate Breakthrough Anti-Fungal Nail Treatment

Triangle Business Journal - HemCon Announces Development Agreement for a sterile, single-use antibody capture device for the removal of isoagglutinin antibodies.

Fox Business & The Earth Times - HemCon Medical Technologies Inc. and ProMetic BioSciences Ltd Announce Collaborative Development Agreement HemCon Announces Further Successful Results from Live Nail Infection Anti-Fungal Study.

 Featured Press Releases   |   See All Press Releases >

U.S. Department of Defense's Committee on Tactical Combat Casualty Care (CoTCCC) updated its guideline recommendations to include HemCon's ChitoGauze hemostatic chitosan-coated gauze product

HemCon Medical Technologies Revenue Growth Surges in Japan

HemCon Medical Technologies Launches Online Sales Initiative Offering Innovative Oral Woundcare Technology
Improving HemCon’s Portfolio Accessibility for 180,000 Dentists and Specialists

HemCon Medical Technologies Builds Global Momentum in Dialysis Market
Targeted roll out of innovative dialysis antibacterial hemostat

HemCon Medical Technologies Aims to Capitalize on European Growth

HemCon Expansion into Dental market plus Research Data to Fuel TriStar Wellness Solutions(R) Continued Growth

TriStar Wellness Solutions® Further Expands Patent Portfolio in Asia
 HemCon’s Chitosan Technology now patented in China

TriStar Wellness Solutions® Obtains New Patent for HemCon’s Chitosan Technology in Japan

TriStar Wellness Solutions(R) Receives One Million Dollar Line of Credit

TriStar Wellness Solutions Appoints Wolfgang Henkel as Acting Managing Director, HemCon Medical Technologies European Subsidiary Proven Industry Leader Will Shape the Future of the Hemcon EU Business

TriStar Wellness Solutions Initiates National Sales Force and Marketing Communications for HemCon Medical Technologies Subsidiary

TriStar Wellness Solutions Obtains U.S. Patent for Manufacturing Process for m.doc™ Bleeding Control Technology Company Plans Comprehensive Launch of m.doc™ Product Line in U.S. OTC Market

TriStar Wellness Solutions Acquires HemCon Medical Technologies
Developer of Bleeding and Wound Management Technologies for Surgical, Health Care, Consumer and Military Markets to Operate as Wholly Owned Subsidiary of TriStar Wellness Solutions

 Media Kit

Included in our press kit, you will find useful information on our company, our achievements and our management.
Download Here
 Multimedia Gallery

Explore the Multimedia Gallery where you can find additional resources videos about HemCon.
Read More

Find out where we are attending and come to meet our team at an event.
Read More